SciSparc SPRC
NASDAQ SPRC
$4.70 -0.20 (-4.18%)
As of: Sep 29, 2026 · 3:57 PM EDT

SciSparc (SPRC) Convertible Debt (2018 - 2025)

Updated

SciSparc (SPRC) reported Convertible Debt of $2.21 million for Q4 2025.

Analysis

SciSparc (SPRC) Convertible Debt (2018 - 2025) Analysis & Trends

Dating back to Q2 2018, SciSparc's Convertible Debt record includes 5 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 SciSparc 609,748.33 1.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.21 Mn
Jun 30, 2025 2.09 Mn
Jun 30, 2019 993,000.00
Dec 31, 2018 779,000.00
Jun 30, 2018 705,000.00
API Access

SciSparc Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=SPRC&period=max&api_key=YOUR_API_KEY